Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
fwzTWF0mrxyHeNLr